CDER has established a meeting program called the Emerging Drug Safety Technology Meeting (EDSTM) program. Learn more.
Similar Posts
In Response to a Broader FDA Investigation, ByHeart Initiates a Voluntary Recall of Two Batches of Infant Formula
[New York, NY] – ByHeart, a next-generation baby nutrition company, announced today that, out of an abundance of caution, it has chosen to voluntarily recall two batches of ByHeart Whole Nutrition Infant Formula following notification from the U.S. Food and Drug Administration (FDA) of a broader ong2024 Safety Communications
Listing of Medical Device 2024 Safety CommunicationsEstaderma – 718714 – 11/03/2025
Unapproved New Drugs/Misbranded BotoxHofood99 Inc Recalls Enoki Mushroom Due to Possible Health Risk
Hofood99 Inc of Brooklyn, NY 11231 is recalling its 200g packages of Enoki Mushroom, because they may be contaminated with Listeria monocytogenesAdvancing Generic Drug Development: Translating Science to Approval – 09/21/2021
KEYNOTE SPEAKER – Janet Woodcock MD, Acting Commissioner of FDAAnesthetic and Analgesic Drug Products Advisory Committee Roster
This page contains the AADPAC roster, which lists the current members and the current number of vacancies for the committee.